OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

Jonker, 2003, Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations, Mol Cell Biol, 23, 7902, 10.1128/MCB.23.21.7902-7908.2003

Motohashi, 2002, Gene expression levels and immunolocalization of organic ion transporters in the human kidney, J Am Soc Nephrol, 13, 866, 10.1681/ASN.V134866

Lee, 2004, Transporters and renal drug elimination, Annu Rev Pharmacol Toxicol, 44, 137, 10.1146/annurev.pharmtox.44.101802.121856

Gerhard, 2002, Structure of renal organic anion and cation transporters, Am J Physiol Renal Physiol, 278, F853

Leabman, 2002, Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function, Pharmacogenetics, 12, 395, 10.1097/00008571-200207000-00007

Fukushima-Uesaka, 2004, Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2), Drug Metab Pharmacokinet, 19, 239, 10.2133/dmpk.19.239

Scheen, 1996, Clinical pharmacokinetics of metformin, Clin Pharmacokinet, 30, 359, 10.2165/00003088-199630050-00003

Dresser, 2002, Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2), Pharm Res, 22, 562

Kimura, 2005, Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1, Drug Metab Pharmacokinet, 20, 379, 10.2133/dmpk.20.379

Somogyi, 1987, Reduction of metformin renal tubular secretion by cimetidine in man, Br J Clin Pharmacol, 23, 545, 10.1111/j.1365-2125.1987.tb03090.x

Cheng, 2001, Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection, J Chromatogr, 762, 51, 10.1016/S0378-4347(01)00342-5

Zendelovska, 2003, Development of an HPLC method for the determination of ranitidine and cimetidine in human plasma following SPE, J Pharm Biomed Anal, 33, 165, 10.1016/S0731-7085(03)00265-6

Niu, 2002, Bayesian haplotype inference for multiple linked single nucleotide polymorphisms, Am J Hum Genet, 70, 157, 10.1086/338446

Tajima, 1989, Statistical method for testing the neutral mutation hypothesis by DNA polymorphism, Genetics, 123, 585, 10.1093/genetics/123.3.585

Li, 1997, Molecular evolution

Tucker, 1981, Metformin kinetics in healthy subjects and in patients with diabetes mellitus, Br J Clin Pharmacol, 12, 235, 10.1111/j.1365-2125.1981.tb01206.x

Yin, 2006, Variability in renal clearance of substrates for renal transporters in Chinese subjects, J Clin Pharmacol, 46, 157, 10.1177/0091270005283838

Barendt, 2002, The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization, J Biol Chem, 277, 22491, 10.1074/jbc.M203114200

Pietig, 2001, Properties and regulation of organic cation transport in freshly isolated human proximal tubules, J Biol Chem, 276, 33741, 10.1074/jbc.M104617200

Biermann, 2006, Characterization of regulatory mechanisms and states of human organic cation transporter 2, Am J Physiol Cell Physiol, 290, C1521, 10.1152/ajpcell.00622.2005

Urban, 2006, Functional genomics of membrane transporters in human populations, Genome Res, 16, 223, 10.1101/gr.4356206

Kerb, 2002, Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences, Pharmacogenetics, 12, 591, 10.1097/00008571-200211000-00002

Shu, 2007, Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action, J Clin Invest, 117, 1422, 10.1172/JCI30558

Pentikainen, 1979, Pharmacokinetics of metformin after intravenous and oral administration to man, Eur J Clin Pharmacol, 16, 195, 10.1007/BF00562061

Sirtori, 1994, Re-evaluation of a biguanide, metformin: mechanism of action and tolerability, Pharm Res, 30, 187, 10.1016/1043-6618(94)80104-5

Hayer-Zillgen, 2002, Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3, Br J Pharmacol, 136, 829, 10.1038/sj.bjp.0704785

Wang, 2002, Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin, J Pharmacol Exp Ther, 302, 510, 10.1124/jpet.102.034140

Masuda, 2006, Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2, J Am Soc Nephrol, 17, 2127, 10.1681/ASN.2006030205

Omote, 2006, The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations, Trends Pharmacol Sci, 27, 587, 10.1016/j.tips.2006.09.001

Burckhardt, 2003, Transport of cimetidine by flounder and human renal organic anion transporter 1, Am J Physiol-Renal Physiol, 284, F503, 10.1152/ajprenal.00290.2002

Cha, 2001, Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney, Molr Pharmacol, 59, 1277, 10.1124/mol.59.5.1277

Bailey, 1996, Metformin, N Engl J Med, 334, 574, 10.1056/NEJM199602293340906

Setter, 2003, Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy, Clin Ther, 25, 2991, 10.1016/S0149-2918(03)90089-0